Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Timolol after myocardial infarction: an answer or a new set of questions?

× No keyword cloud information.

18 in total

1. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors: J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal: N Engl J Med Date: 1978-09-28 Impact factor: 91.245

2. Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviour.

Authors: J R Hampton; M J Harrison; A J Honour; J R Mitchell; J S Prichard
Journal: Cardiovasc Res Date: 1972-11 Impact factor: 10.787

3. Platelet behaviour and drugs used in cardiovascular disease.

Authors: J R Hampton; M J Harrison; A J Honour; J R Mitchell
Journal: Cardiovasc Res Date: 1967-04 Impact factor: 10.787

4. Protective influence of cardiac denervation against arrhythmias of myocardial infarction.

Authors: S F Schaal; A G Wallace; W C Sealy
Journal: Cardiovasc Res Date: 1969-07 Impact factor: 10.787

Review 5. Presentation and analysis of the results of clinical trials in cardiovascular disease.

Authors: J R Hampton
Journal: Br Med J (Clin Res Ed) Date: 1981-04-25

6. A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction.

Authors: J D Hill; J R Hampton; J R Mitchell
Journal: Lancet Date: 1978-04-22 Impact factor: 79.321

7. Effect of propranolol in myocardial infarction.

Authors: P J Snow
Journal: Lancet Date: 1965-09-18 Impact factor: 79.321

8. Platelet-release reaction in myocardial infarction.

Authors: S Heptinstall; G P Mulley; P M Taylor; J R Mitchell
Journal: Br Med J Date: 1980-01-12

9. Clinical events resulting from thrombus formation.

Authors: J R Mitchell
Journal: Br Med Bull Date: 1978-05 Impact factor: 4.291

10. Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results.

Authors: M P Andersen; P Bechsgaard; J Frederiksen; D A Hansen; H J Jürgensen; B Nielsen; F Pedersen; O Pedersen-Bjergaard; S L Rasmussen
Journal: Lancet Date: 1979-10-27 Impact factor: 79.321

6 in total

Timolol after myocardial infarction: an answer or a new set of questions?

1. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

2. Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviour.

3. Platelet behaviour and drugs used in cardiovascular disease.

4. Protective influence of cardiac denervation against arrhythmias of myocardial infarction.

Review 5. Presentation and analysis of the results of clinical trials in cardiovascular disease.

6. A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction.

7. Effect of propranolol in myocardial infarction.

8. Platelet-release reaction in myocardial infarction.

9. Clinical events resulting from thrombus formation.

10. Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results.

Review 1. Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction.

2. Applying results of randomised trials to clinical practice: impact of losses before randomisation.

3. Statistics in question. Assessing methods--art of significance testing.

4. Audit in renal failure; the wrong target?

5. Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists.

6. Systematic reviews in context: highlighting systematic reviews relevant to Africa in the Pan African Medical Journal.